Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Thyroid Neoplasms 1Multiple Pulmonary Nodules 1Multiple Advanced Tumors After PD-1 Therapy Failure 1Gastritis, Atrophic 1Desmoid Tumors 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Cancer Pain 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy 2Specimen Handling 1Risk Assessment 1Radiofrequency Ablation 1Mass Screening 1Itraconazole 1Gastroscopy 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Barrett Esophagus × Radiofrequency Ablation × Clear all
NCT06732388 2026-05-13

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
64 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡